153 related articles for article (PubMed ID: 15284123)
41. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
[TBL] [Abstract][Full Text] [Related]
42. Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells.
Hattori N; Nishino K; Ko YG; Hattori N; Ohgane J; Tanaka S; Shiota K
J Biol Chem; 2004 Apr; 279(17):17063-9. PubMed ID: 14761969
[TBL] [Abstract][Full Text] [Related]
43. DNA methylation inhibitor causes cell growth retardation and gene expression changes in feline lymphoma cells.
Fujita M; Kaneda M
J Vet Med Sci; 2017 Aug; 79(8):1352-1358. PubMed ID: 28652519
[TBL] [Abstract][Full Text] [Related]
44. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.
Heckman CA; Duan H; Garcia PB; Boxer LM
Oncogene; 2006 Feb; 25(6):888-98. PubMed ID: 16186795
[TBL] [Abstract][Full Text] [Related]
45. Class switch recombination was specifically targeted to immunoglobulin (Ig)G4 or IgA in Hodgkin's disease-derived cell lines.
Irsch J; Wolf J; Tesch H; Diehl V; Radbruch A; Staratschek-Jox A
Br J Haematol; 2001 Jun; 113(3):785-93. PubMed ID: 11380471
[TBL] [Abstract][Full Text] [Related]
46. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
[TBL] [Abstract][Full Text] [Related]
47. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
48. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
[TBL] [Abstract][Full Text] [Related]
49. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
50. Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cells.
Jox A; Zander T; Küppers R; Irsch J; Kanzler H; Kornacker M; Bohlen H; Diehl V; Wolf J
Blood; 1999 Jun; 93(11):3964-72. PubMed ID: 10339506
[TBL] [Abstract][Full Text] [Related]
51. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
52. Stress chaperones, mortalin, and pex19p mediate 5-aza-2' deoxycytidine-induced senescence of cancer cells by DNA methylation-independent pathway.
Widodo N; Deocaris CC; Kaur K; Hasan K; Yaguchi T; Yamasaki K; Sugihara T; Ishii T; Wadhwa R; Kaul SC
J Gerontol A Biol Sci Med Sci; 2007 Mar; 62(3):246-55. PubMed ID: 17389721
[TBL] [Abstract][Full Text] [Related]
53. [Histone H3 lysine 9 methylation is associated with the expression of hMLH1 and DNA methylation in gastric cancer cells].
Meng CF; Zhu XJ; Peng G
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2490-3. PubMed ID: 19080631
[TBL] [Abstract][Full Text] [Related]
54. Transcriptional regulation of the murine 3' IgH enhancer by OCT-2.
Tang H; Sharp PA
Immunity; 1999 Nov; 11(5):517-26. PubMed ID: 10591177
[TBL] [Abstract][Full Text] [Related]
55. Silencing of the thrombomodulin gene in human malignant melanoma.
Furuta J; Kaneda A; Umebayashi Y; Otsuka F; Sugimura T; Ushijima T
Melanoma Res; 2005 Feb; 15(1):15-20. PubMed ID: 15714116
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
[TBL] [Abstract][Full Text] [Related]
57. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
[TBL] [Abstract][Full Text] [Related]
58. Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin-derived cell lines: activation of immature lymphoid cells in Hodgkin's disease.
Falk MH; Tesch H; Stein H; Diehl V; Jones DB; Fonatsch C; Bornkamm GW
Int J Cancer; 1987 Aug; 40(2):262-9. PubMed ID: 3112032
[TBL] [Abstract][Full Text] [Related]
59. Activation of oncogenic pathways in classical Hodgkin lymphoma by decitabine: A rationale for combination with small molecular weight inhibitors.
Swerev TM; Wirth T; Ushmorov A
Int J Oncol; 2017 Feb; 50(2):555-566. PubMed ID: 28035374
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
